Follow
CAR-T biomarker discovery
Chimeric antigen receptor (CAR) T cell therapy is an emerging form of immunotherapy which engineers a patient's immune cells to better identify and kill cancer cells. While CAR-T cell therapy can cure hard-to-treat cancers, only a small proportion of patients respond favorably. Identifying biomarkers, biological molecules that be predict how a person may respond to a treatment, can help doctors determine which patients will benefit from this therapy. Because CAR-T cell therapy is costly and time-consuming, there is an effort to promote research focused on discovering biomarkers to manage treatment.
-
NOV 08, 2023Cancer
Adoptive cell therapy has emerged as a promising alternative treatment for hematological and solid cancers, with CAR-T t ...Sponsored By: Sino BiologicalOCT 17, 2023Cancer
Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve ...Sponsored By: Sino BiologicalMAY 31, 2021Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...Written By: Tara FernandesAPR 13, 2020Cancer
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac ...Written By: Jasper CantrellJAN 23, 2019Cardiology
A host of new discoveries bring medicine closer to the goal of ending heart attacks. These include new protective method ...Written By: Abbie ArceAUG 28, 2018Cell & Molecular Biology
Neutrophils are a highly abundant type of immune cell, outnumbering every other kind that runs through the bloodstream.Written By: Carmen Leitch
NOV 08, 2023
Cancer
Adoptive cell therapy has emerged as a promising alternative treatment for hematological and solid cancers, with CAR-T t
...
Sponsored By:
Sino Biological
OCT 17, 2023
Cancer
Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve
...
Sponsored By:
Sino Biological
MAY 31, 2021
Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors.
...
Written By:
Tara Fernandes
APR 13, 2020
Cancer
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac
...
Written By:
Jasper Cantrell
JAN 23, 2019
Cardiology
A host of new discoveries bring medicine closer to the goal of ending heart attacks. These include new protective method
...
Written By:
Abbie Arce
AUG 28, 2018
Cell & Molecular Biology
Neutrophils are a highly abundant type of immune cell, outnumbering every other kind that runs through the bloodstream.
Written By:
Carmen Leitch